原发性中叶肺癌的诊断与治疗  被引量:20

Diagnosis and Surgical Treatment of Middle Lobe Carcinoma of the Lung

在线阅读下载全文

作  者:赵一昕[1] 许栋生[1] 朱亚玲[1] 张家麒[1] 张伯生[1] 邹卫[1] 

机构地区:[1]南京胸科医院胸心外科

出  处:《中华胸心血管外科杂志》1998年第1期21-23,共3页Chinese Journal of Thoracic and Cardiovascular Surgery

摘  要:中叶病变多因肺部感染所致,中叶肺癌发生率低而易误诊。为探讨中叶肺癌早期诊断和以手术为主综合治疗效果,总结11年间手术治疗39例中叶肺癌(占同期肺癌手术总例数的5.1%)。手术切除34例(87.18%),开胸探查5例。手术方式以中叶切除和双肺叶切除为多。23例术后辅以化疗或加免疫治疗。随访率为92.3%。23例术后化疗和免疫治疗者其1、3、5年生存率分别为86.95%、43.48%、30.43%。术后未作辅助治疗的13例其1、3、5年生存率分别为69.23%、30.77%、15.38%。二组生存率相比有显著差异(P<0.05)。本组中晚期肺癌占多数,病理类型以腺癌居多。影响生存率的因素为病理分期、组织学和纵隔淋巴结转移。Aim:To review the experience of surgical management of middle lobe carcinoma of the lung.Clinical material and method:Between 1983 and 1994,39 patients with middle lobe carcinoma of the lung were treated surgically,accounting for 51% of the lung cancers treated at the same period.There were 26 men and 13 women with a mean age of 52.2 years.Resection was performed in 34 patients and exploration alone in 5 patients.By postresection staging,5 patients (12.88%) had stage I tumor,13 (33.33%) had stage II and 21 (53.84%) had stage III tumor.Surgical procedures included simple lobectomy in 58.82%,bilobectomy in 26.47%,right pneumonectomy in 11.76% and wedge resection in 2.94%. Postoperative chemotherapy or immunotherapy was carried out in 23 patients (combined therapy group). 92.3% of patients were followed up.Result:The resectability rate was 87.18%.There was no operative death.The postoperative morbidity rate was 7.7%.Overall one,three and fiveyear survival rates were 86.95%,43.48% and 30.43%,respectively.For surgical group,the 1,3 and 5year survival rates were 69.23%,30.77% and 15.38%,respectively.There was significant difference in longterm survival between combined therapy group and surgical group (P<0.05).Conclusion:Longterm survival rate is related to tumor staging,pathologic type of tumor and mediastinal lymph node metastases.The combined therapy after surgery may improve survival rate.

关 键 词:肺肿瘤 原发性 中叶病变 诊断 外科手术 

分 类 号:R734.2[医药卫生—肿瘤] R730.56[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象